Initial treatment for polypoidal choroidal vasculopathy: Ranibizumab combined with photodynamic therapy or fixed-dosing aflibercept monotherapy.

CONCLUSION: The intravitreal ranibizumab-photodynamic therapy combination therapy was noninferior to fixed-dosing intravitreal aflibercept monotherapy in improving visual acuity and required fewer injections.
PMID: 31476891 [PubMed - as supplied by publisher]

Source: European Journal of Ophthalmology - September 1, 2019 Category: Opthalmology Authors: Yoneda A, Wakiyama H, Kurihara J, Kitaoka T Tags: Eur J Ophthalmol Source Type: research